title: Recombinant Swinepox Virus for Veterinary Vaccine Development.
abstract: Poxvirus-vectors have been widely used in vaccine development for several important human and animal diseases; some of these vaccines have been licensed and used extensively. Swinepox virus (SPV) is well suited to develop recombinant vaccines because of its large packaging capacity for recombinant DNA, its host range specificity, and its ability to induce appropriate immune responses.
authors.affiliation: College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang Rd., Nanjing, Jiangsu, 210095, China. fhj@njau.edu.cn.
authors.forename: Hong-Jie
authors.initials: HJ
authors.lastname: Fan
authors.affiliation: College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang Rd., Nanjing, Jiangsu, 210095, China.
authors.forename: Hui-Xing
authors.initials: HX
authors.lastname: Lin
mesh_terms: D000818:Animals; D004274:DNA, Recombinant / Q000235:genetics / Q000276:immunology; D005822:Genetic Vectors; D006801:Humans; D018148:Suipoxvirus / Q000235:genetics* / Q000276:immunology; D014611:Vaccination / Q000379:methods* / Q000662:veterinary; D014614:Vaccines, Synthetic / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D004274:DNA, Recombinant; D014614:Vaccines, Synthetic
keywords: Homologous recombination; Swinepox virus; Vaccine